Advertisement

Virchows Archiv

, Volume 469, Issue 6, pp 669–678 | Cite as

Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant

  • Maria Pané Foix
  • Ana Dunatov
  • Petr Martinek
  • Enric Condom Mundó
  • Saul Suster
  • Maris Sperga
  • Jose I. Lopez
  • Monika Ulamec
  • Stela Bulimbasic
  • Delia Perez Montiel
  • Reza Alaghehbandan
  • Kvetoslava Peckova
  • Krystina Pivovarcikova
  • Daum Ondrej
  • Pavla Rotterova
  • Faruk Skenderi
  • Kristyna Prochazkova
  • Martin Dusek
  • Milan Hora
  • Michal Michal
  • Ondrej HesEmail author
Original Article

Abstract

Chromophobe renal cell carcinoma (ChRCC) is typically composed of large leaf-like cells and smaller eosinophilic cells arranged in a solid-alveolar pattern. Eosinophilic, adenomatoid/pigmented, or neuroendocrine variants have also been described. We collected 10 cases of ChRCC with a distinct multicystic pattern out of 733 ChRCCs from our registry, and subsequently analyzed these by morphology, immunohistochemistry, and array comparative genomic hybridization. Of the 10 patients, 6 were males with an age range of 50–89 years (mean 68, median 69). Tumor size ranged between 1.2 and 20 cm (mean 5.32, median 3). Clinical follow-up was available for seven patients, ranging 1–19 years (mean 7.2, median 2.5). No aggressive behavior was documented. We observed two growth patterns, which were similar in all tumors: (1) variable-sized cysts, resembling multilocular cystic neoplasm of low malignant potential and (2) compressed cystic and tubular pattern with slit-like spaces. Raisinoid nuclei were consistently present while necrosis was absent in all cases. Half of the cases showed eosinophilic/oncocytic cytology, deposits of pigment (lipochrome) and microcalcifications. The other half was composed of pale or mixed cell populations. Immunostains for epithelial membrane antigen (EMA), CK7, OSCAR, CD117, parvalbumin, MIA, and Pax 8 were positive in all tumors while negative for vimentin, TFE3, CANH 9, HMB45, cathepsin K, and AMACR. Ki67 immunostain was positive in up to 1 % of neoplastic cells. Molecular genetic examination revealed multiple chromosomal losses in two fifths analyzable tumors, while three cases showed no chromosomal numerical aberrations. ChRCC are rarely arranged in a prominent multicystic pattern, which is probably an extreme form of the microcystic adenomatoid pigmented variant of ChRCC. The spectrum of tumors entering the differential diagnosis of ChRCC is quite different from that of conventional ChRCC. The immunophenotype of ChRCC is identical with that of conventional ChRCC. Chromosomal numerical aberration pattern was variable; no chromosomal numerical aberrations were found in three cases. All the cases in this series have shown an indolent and non-aggressive behavior.

Keywords

Kidney Chromophobe renal cell carcinoma Multicystic Immunohistochemistry ArrayCGH 

Notes

Compliance with ethical standards

Study design has been approved by local ethical committee (Charles University, Medical School Plzen) LEK FN Plzeň.

Funding

The study was supported by the Charles University Research Fund (project number P36), by the project FN 00669806, and by SVV 260283.

Conflict of interest

All authors declare no conflict of interest

References

  1. 1.
    Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A, Menon M (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26(3):281–291CrossRefPubMedGoogle Scholar
  2. 2.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H (2008) Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol 32(12):1822–1834. doi: 10.1097/PAS.0b013e3181831e68 CrossRefPubMedGoogle Scholar
  3. 3.
    Michal M, Hes O, Svec A, Ludvikova M (1998) Pigmented microcystic chromophobe cell carcinoma: a unique variant of renal cell carcinoma. Ann Diagn Pathol 2(3):149–153CrossRefPubMedGoogle Scholar
  4. 4.
    Kuroda N, Tanaka A, Yamaguchi T, Kasahara K, Naruse K, Yamada Y, Hatanaka K, Shinohara N, Nagashima Y, Mikami S, Oya M, Hamashima T, Michal M, Hes O (2013) Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors. Medical molecular morphology 46(1):49–55. doi: 10.1007/s00795-012-0007-7 CrossRefPubMedGoogle Scholar
  5. 5.
    Hes O, Vanecek T, Perez-Montiel DM, Alvarado Cabrero I, Hora M, Suster S, Lamovec J, Curik R, Mandys V, Michal M (2005) Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation—a diagnostic pitfall. Morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Archiv: an international journal of pathology 446(4):383–393. doi: 10.1007/s00428-004-1187-x CrossRefGoogle Scholar
  6. 6.
    Dundr P, Pesl M, Povysil C, Tvrdik D, Pavlik I, Soukup V, Dvoracek J (2007) Pigmented microcystic chromophobe renal cell carcinoma. Pathol Res Pract 203(8):593–597. doi: 10.1016/j.prp.2007.05.005 CrossRefPubMedGoogle Scholar
  7. 7.
    Kuroda N, Iiyama T, Moriki T, Shuin T, Enzan H (2005) Chromophobe renal cell carcinoma with focal papillary configuration, nuclear basaloid arrangement and stromal osseous metaplasia containing fatty bone marrow element. Histopathology 46(6):712–713. doi: 10.1111/j.1365-2559.2005.02032.x CrossRefPubMedGoogle Scholar
  8. 8.
    Parada DD, Pena KB (2008) Chromophobe renal cell carcinoma with neuroendocrine differentiation. APMIS 116(9):859–865CrossRefPubMedGoogle Scholar
  9. 9.
    Kuroda N, Tamura M, Hes O, Michal M, Gatalica Z (2011) Chromophobe renal cell carcinoma with neuroendocrine differentiation and sarcomatoid change. Pathol Int 61(9):552–554. doi: 10.1111/j.1440-1827.2011.02689.x CrossRefPubMedGoogle Scholar
  10. 10.
    Thoenes W, Storkel S, Rumpelt HJ, Moll R, Baum HP, Werner S (1988) Chromophobe cell renal carcinoma and its variants—a report on 32 cases. J Pathol 155(4):277–287. doi: 10.1002/path.1711550402 CrossRefPubMedGoogle Scholar
  11. 11.
    Moch H, Humphrey PA, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs (World Health Organization classification of tumours). IARC Press, Lyon, 356 ppGoogle Scholar
  12. 12.
    Peckova K, Martinek P, Ohe C, Kuroda N, Bulimbasic S, Condom Mundo E, Perez Montiel D, Lopez JI, Daum O, Rotterova P, Kokoskova B, Dubova M, Pivovarcikova K, Bauleth K, Grossmann P, Hora M, Kalusova K, Davidson W, Slouka D, Miroslav S, Buzrla P, Hynek M, Michal M, Hes O (2015) Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature. Ann Diagn Pathol 19(4):261–268. doi: 10.1016/j.anndiagpath.2015.05.001 CrossRefPubMedGoogle Scholar
  13. 13.
    Akhtar M, Tulbah A, Kardar AH, Ali MA (1997) Sarcomatoid renal cell carcinoma: the chromophobe connection. Am J Surg Pathol 21(10):1188–1195CrossRefPubMedGoogle Scholar
  14. 14.
    Itoh T, Chikai K, Ota S, Nakagawa T, Takiyama A, Mouri G, Shinohara N, Yamashita T, Suzuki S, Koyanagi T, Nagashima K (2002) Chromophobe renal cell carcinoma with osteosarcoma-like differentiation. Am J Surg Pathol 26(10):1358–1362CrossRefPubMedGoogle Scholar
  15. 15.
    Magro G, Lopes M, Amico P, Puzzo L (2005) Chromophobe renal cell carcinoma with extensive rhabdomyosarcomatous component. Virchows Archiv: an international journal of pathology 447(5):894–896. doi: 10.1007/s00428-005-0026-z CrossRefGoogle Scholar
  16. 16.
    Quiroga-Garza G, Khurana H, Shen S, Ayala AG, Ro JY (2009) Sarcomatoid chromophobe renal cell carcinoma with heterologous sarcomatoid elements. A case report and review of the literature. Archives of pathology & laboratory medicine 133(11):1857–1860. doi: 10.1043/1543-2165-133.11.1857 Google Scholar
  17. 17.
    Anila KR, Mathew AP, Somanathan T, Mathews A, Jayasree K (2012) Chromophobe renal cell carcinoma with heterologous (liposarcomatous) differentiation: a case report. Int J Surg Pathol 20(4):416–419. doi: 10.1177/1066896911429298 CrossRefPubMedGoogle Scholar
  18. 18.
    Petersson F, Michal M, Franco M, Hes O (2010) Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation—report of a unique case. International journal of clinical and experimental pathology 3(5):534–540PubMedPubMedCentralGoogle Scholar
  19. 19.
    Husain A, Eigl BJ, Trpkov K (2014) Composite chromophobe renal cell carcinoma with sarcomatoid differentiation containing osteosarcoma, chondrosarcoma, squamous metaplasia and associated collecting duct carcinoma: a case report. Analytical and quantitative cytopathology and histopathology 36(4):235–240PubMedGoogle Scholar
  20. 20.
    Cochand-Priollet B, Molinie V, Bougaran J, Bouvier R, Dauge-Geffroy MC, Deslignieres S, Fournet JC, Gros P, Lesourd A, Saint-Andre JP, Toublanc M, Vieillefond A, Wassef M, Fontaine A, Groleau L (1997) Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases. Archives of pathology & laboratory medicine 121(10):1081–1086Google Scholar
  21. 21.
    DeLong W, Sakr W (1996) Chromophobe renal cell carcinoma: a comparative histochemical and immunohistochemical study. J Urol Pathol 4:1–8Google Scholar
  22. 22.
    Taki A, Nakatani Y, Misugi K, Yao M, Nagashima Y (1999) Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 12(3):310–317Google Scholar
  23. 23.
    Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C (2004) KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 28(5):676–678CrossRefPubMedGoogle Scholar
  24. 24.
    Wu SL, Kothari P, Wheeler TM, Reese T, Connelly JH (2002) Cytokeratins 7 and 20 Immunoreactivity in chromophobe renal cell carcinomas and renal oncocytomas. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 15(7):712–717CrossRefGoogle Scholar
  25. 25.
    Mathers ME, Pollock AM, Marsh C, O’Donnell M (2002) Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 40(6):563–567. doi: 10.1046/j.1365-2559.2002.01397.x CrossRefPubMedGoogle Scholar
  26. 26.
    Liu L, Qian J, Singh H, Meiers I, Zhou X, Bostwick DG (2007) Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis. Archives of pathology & laboratory medicine 131(8):1290–1297. doi: 10.1043/1543-2165(2007)131[1290:IAOCRC]2.0.CO;2 Google Scholar
  27. 27.
    Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L (2005) Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 18(2):161–169. doi: 10.1038/modpathol.3800286 CrossRefGoogle Scholar
  28. 28.
    Gunawan B, Bergmann F, Braun S, Hemmerlein B, Ringert RH, Jakse G, Fuzesi L (1999) Polyploidization and losses of chromosomes 1, 2, 6, 10, 13, and 17 in three cases of chromophobe renal cell carcinomas. Cancer Genet Cytogenet 110(1):57–61CrossRefPubMedGoogle Scholar
  29. 29.
    Brunelli M, Gobbo S, Cossu-Rocca P, Cheng L, Hes O, Delahunt B, Pea M, Bonetti F, Mina MM, Ficarra V, Chilosi M, Eble JN, Menestrina F, Martignoni G (2007) Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 20(3):303–309. doi: 10.1038/modpathol.3800739 CrossRefGoogle Scholar
  30. 30.
    Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, Khoo SK, Sugimura J, Fujioka T, Furge KA, Kort E, Giraud S, Ferlicot S, Vielh P, Amsellem-Ouazana D, Debre B, Flam T, Thiounn N, Zerbib M, Benoit G, Droupy S, Molinie V, Vieillefond A, Tan PH, Richard S, Teh BT (2010) Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer 10:196. doi: 10.1186/1471-2407-10-196 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Vieira J, Henrique R, Ribeiro FR, Barros-Silva JD, Peixoto A, Santos C, Pinheiro M, Costa VL, Soares MJ, Oliveira J, Jeronimo C, Teixeira MR (2010) Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies. Genes, chromosomes & cancer 49(10):935–947. doi: 10.1002/gcc.20805 CrossRefGoogle Scholar
  32. 32.
    Speicher MR, Schoell B, du Manoir S, Schrock E, Ried T, Cremer T, Storkel S, Kovacs A, Kovacs G (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145(2):356–364PubMedPubMedCentralGoogle Scholar
  33. 33.
    Verdorfer I, Hobisch A, Hittmair A, Duba HC, Bartsch G, Utermann G, Erdel M (1999) Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification. Cancer Genet Cytogenet 111:61–70Google Scholar
  34. 34.
    Bugert P, Gaul C, Weber K, Herbers J, Akhtar M, Ljungberg B, Kovacs G (1997) Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Laboratory investigation; a journal of technical methods and pathology 76(2):203–208PubMedGoogle Scholar
  35. 35.
    Iqbal MA, Akhtar M, Ali MA (1996) Cytogenetic findings in renal cell carcinoma. Hum Pathol 27(9):949–954CrossRefPubMedGoogle Scholar
  36. 36.
    Sperga M, Martinek P, Vanecek T, Grossmann P, Bauleth K, Perez-Montiel D, Alvarado-Cabrero I, Nevidovska K, Lietuvietis V, Hora M, Michal M, Petersson F, Kuroda N, Suster S, Branzovsky J, Hes O (2013) Chromophobe renal cell carcinoma—chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases. Virchows Archiv: an international journal of pathology 463(4):563–573. doi: 10.1007/s00428-013-1457-6 CrossRefGoogle Scholar
  37. 37.
    Zhang Q, Ma J, Wu CY, Zhang DH, Zhao M (2015) Tubulocystic oncocytoma of the kidney: a case study and review of literature with focus on implications for differential diagnosis. International journal of clinical and experimental pathology 8(11):14786–14792PubMedPubMedCentralGoogle Scholar
  38. 38.
    Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Trpkov K, Vesela P, Hora M, Kalusova K, Sperga M, Perez Montiel D, Alvarado Cabrero I, Bulimbasic S, Branzovsky J, Michal M, Hes O (2016) Cystic renal oncocytoma and tubulocystic renal cell carcinoma: morphologic and immunohistochemical comparative study. Applied immunohistochemistry & molecular morphology: AIMM / official publication of the Society for Applied Immunohistochemistry 24(2):112–119. doi: 10.1097/pai.0000000000000156 CrossRefGoogle Scholar
  39. 39.
    Eble JN, Bonsib SM (1998) Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis. Semin Diagn Pathol 15(1):2–20PubMedGoogle Scholar
  40. 40.
    Tickoo SK, Lee MW, Eble JN, Amin M, Christopherson T, Zarbo RJ, Amin MB (2000) Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol 24(9):1247–1256CrossRefPubMedGoogle Scholar
  41. 41.
    MacLennan GT, Farrow GM, Bostwick DG (1997) Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin. Urology 50(5):679–684. doi: 10.1016/s0090-4295(97)00335-x CrossRefPubMedGoogle Scholar
  42. 42.
    MacLennan GT, Bostwick DG (2005) Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors. Clin Lab Med 25(2):393–416. doi: 10.1016/j.cll.2005.01.005 CrossRefPubMedGoogle Scholar
  43. 43.
    Hora M, Urge T, Eret V, Stransky P, Klecka J, Kreuzberg B, Ferda J, Hyrsl L, Breza J, Holeckova P, Mego M, Michal M, Petersson F, Hes O (2011) Tubulocystic renal carcinoma: a clinical perspective. World J Urol 29(3):349–354. doi: 10.1007/s00345-010-0614-7 CrossRefPubMedGoogle Scholar
  44. 44.
    Khalaf I, El-Badawy N, Shawarby MA (2013) Tubulocystic renal cell carcinoma, a rare tumor entity: review of literature and report of a case. Afr J Urol 19(1):1–6. doi: 10.1016/j.afju.2012.12.001 CrossRefGoogle Scholar
  45. 45.
    Tran T, Jones CL, Williamson SR, Eble JN, Grignon DJ, Zhang S, Wang M, Baldridge LA, Wang L, Montironi R, Scarpelli M, Tan PH, Simper NB, Comperat E, Cheng L (2015) Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma. Histopathology. doi: 10.1111/his.12840 Google Scholar
  46. 46.
    Michal M, Syrucek M (1998) Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract 194(6):445–448. doi: 10.1016/s0344-0338(98)80038-1 CrossRefPubMedGoogle Scholar
  47. 47.
    Adsay NV, Eble JN, Srigley JR, Jones EC, Grignon DJ (2000) Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol 24(7):958–970CrossRefPubMedGoogle Scholar
  48. 48.
    Kum JB, Grignon DJ, Wang M, Zhou M, Montironi R, Shen SS, Zhang S, Lopez-Beltran A, Eble JN, Cheng L (2011) Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol 35(8):1114–1122. doi: 10.1097/PAS.0b013e3182233fb6 CrossRefPubMedGoogle Scholar
  49. 49.
    Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R (2009) Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol 33(12):1840–1849. doi: 10.1097/PAS.0b013e3181be22d1 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Maria Pané Foix
    • 1
    • 2
  • Ana Dunatov
    • 3
  • Petr Martinek
    • 4
  • Enric Condom Mundó
    • 1
    • 2
  • Saul Suster
    • 5
  • Maris Sperga
    • 6
  • Jose I. Lopez
    • 7
  • Monika Ulamec
    • 8
  • Stela Bulimbasic
    • 9
  • Delia Perez Montiel
    • 10
  • Reza Alaghehbandan
    • 11
  • Kvetoslava Peckova
    • 4
  • Krystina Pivovarcikova
    • 4
  • Daum Ondrej
    • 4
  • Pavla Rotterova
    • 4
  • Faruk Skenderi
    • 12
  • Kristyna Prochazkova
    • 13
  • Martin Dusek
    • 4
  • Milan Hora
    • 13
  • Michal Michal
    • 4
  • Ondrej Hes
    • 4
    • 14
    Email author
  1. 1.Department of Pathology, Bellvitge University HospitalBellvitge Biomedical Research Institute (IDIBELL)BarcelonaSpain
  2. 2.Department of Pathology and Experimental Therapeutics, School of MedicineUniversity of BarcelonaBarcelonaSpain
  3. 3.Department of PathologyUniversity of SplitSplitCroatia
  4. 4.Department of Pathology, , Medical Faculty and Charles University Hospital PlzenCharles UniversityPilsenCzech Republic
  5. 5.Department of PathologyMedical College of WisconsinMilwaukeeUSA
  6. 6.Department of PathologyEast UniversityRigaLatvia
  7. 7.Department of Pathology, Cruces University Hospital, Biocruces Research InstituteUniversity of the Basque CountryBarakaldoSpain
  8. 8.“Ljudevit Jurak” Pathology DepartmentClinical Hospital Center “Sestre milosrdnice”ZagrebCroatia
  9. 9.Department of PathologyClinical Hospital Center ZagrebZagrebCroatia
  10. 10.Department of PathologyInstituto Nacional de CancerologiaMexico CityMexico
  11. 11.Department of Pathology, Faculty of Medicine, Royal Columbian HospitalUniversity of British ColumbiaVancouverCanada
  12. 12.Department of PathologyClinical Center of the University of SrajevoSarajevoBosnia and Herzegovina
  13. 13.Department of Urology, Medical Faculty and Charles University HospitalCharles UniversityPlzenCzech Republic
  14. 14.Biomedical Centre, Faculty of Medicine in LzenCharles University in PraguePlzenCzech Republic

Personalised recommendations